Our Technology
Our Platform
Our modular platform unlocks infinite in vivo cell & gene therapy product opportunities
CELLfinity Platform
TQx is developing a modular target cell-specific modification platform for the generation of infinite in vivo cell & gene therapy product opportunities
Drug Delivery System
Automated drug delivery application system
The CELLbricator system enables our CELLbriX PRO & CELLbriX ULTRA process. The system combines highly automated targeted cell selection and genetic manipulation within one step. The T-FABfinity technology is an integrated component of our system enabling safe and selective in vivo therapy delivery
Cell Selection (T-FABfinity)
TQ Therapeutics’ proprietary T-FABfinity cell selection technology, an affinity and column-based cell isolation technology is a closed, automated module for fast, residual-free positive cell selection of untouched CD3+ T target cells from sources such as whole blood and apheresis products. The module will deliver high-purity cell enrichment in under two hours, streamlining workflows.
Marker Library: We can extend our cell selection markers to any cell type that is expressing an antigen on their surface (e.g. NK cells, B-Cells…)
Cell Activation (FABtivate)
The FABtivate activation reagent is a soluble, three-component protein complex composed of a multimerized Streptactin backbone functionalized with kinetically optimized anti-CD3 and anti-CD28 Fab fragments. Designed for in vitro stimulation and expansion of human T cells, FABtivate is particularly optimized for automated cell manufacturing systems.
It delivers robust, physiological T cell activation with precise control over stimulation (strength and duration). The activation signal can be rapidly and completely terminated by administering D-Biotin, which triggers dissociation of the complex and enables full removal of FABtivate residuals during downstream processing. FABtivate is seamlessly integratable in our CELLbriX PRO Process.
You might be interested in
Get in touch!
If you are interested in our technology or platform, feel free to reach out!
TQ Therapeutics GmbH
Fraunhoferstr. 1
82152 Planegg Germany
Phone: +49 89 / 248 870 4 - 50
Email: info@tqtherapeutics.com